Pulmosis capsule should be taken orally with water, with or without food, at the same time each day.

Pulmosin works by selectively inhibiting phosphodiesterase-4 (PDE4), an enzyme found in inflammatory cells. This inhibition leads to an increase in intracellular cyclic AMP (cAMP) levels, which in turn reduces inflammation and relaxes smooth muscles in the airways, thereby improving lung function and reducing COPD exacerbations.

• •Hypersensitivity to Pulmosin or any component of the formulation.
• •Moderate to severe liver impairment.
• •Patients with acute unstable cardiac conditions.
• •History of depression associated with suicidal ideation.

Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.

Symptoms of overdose may include severe nausea, vomiting, diarrhea, abdominal pain, and headache. In case of overdose, symptomatic and supportive measures should be initiated. There is no specific antidote.

Pregnancy Category C. Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is unknown whether Pulmosin is excreted in human milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.